As of Feb 23
| +1.80 / +1.90%|
The 2 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 102.50, with a high estimate of 110.00 and a low estimate of 95.00. The median estimate represents a +6.27% increase from the last price of 96.45.
The current consensus among 3 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.